or
forgot password

The Impact of the Human Papilloma Virus in Pediatric Chronic Kidney Disease, Dialysis, and Transplant Patients


N/A
9 Years
18 Years
Open (Enrolling)
Female
Chronic Kidney Disease, Dialysis

Thank you

Trial Information

The Impact of the Human Papilloma Virus in Pediatric Chronic Kidney Disease, Dialysis, and Transplant Patients


Inclusion Criteria:



- 9-18-year-old girls who have CKD stages 3 or 4 (Glomerular filtration rates 15-59
mL/min/1.73m2).

- 9-18-year-old girls who are on dialysis.

- 9-18-year-old girls who have had a functioning kidney transplant for longer than 6
months and are on the same immunosuppression regimen.

- Healthy 9-18-year-old girls

Exclusion Criteria:

- Pregnancy, fever, allergy to any vaccine component, any immune disorder and any blood
product received in the previous 6 months.

Type of Study:

Observational

Study Design:

Time Perspective: Prospective

Principal Investigator

Corina Nailescu, M.D.

Investigator Role:

Principal Investigator

Investigator Affiliation:

Indiana University/Riley Children's Hospital

Authority:

United States: Institutional Review Board

Study ID:

0807-02

NCT ID:

NCT00767897

Start Date:

November 2011

Completion Date:

November 2014

Related Keywords:

  • Chronic Kidney Disease
  • Dialysis
  • Dose response relationship
  • immunity
  • Kidney Diseases
  • Papilloma
  • Renal Insufficiency, Chronic
  • Kidney Failure, Chronic

Name

Location
Indiana University/Riley Children's Hospital Indianapolis, Indiana  46202